CytoTronics enables optics-free imaging for drug discovery through its complementary metal-oxide-semiconductor (CMOS) electronics platform. Building upon a suite of innovations licensed from Harvard University, CytoTronics's technology measures and manipulates live cells to produce real-time, high resolution electrical and electrochemical cell-based assays. By providing unique single-cell resolution readouts that are not currently available in today's cell-based drug screening market, CytoTronics is enhancing the accuracy of cell-biology information that can be used to revolutionize drug discovery.

Key Contact

Funding Events

Date	Amount	Type	Investors	Valuation
04/28/22	$9,250,000	Seed	Anzu Partners BoxOne Ventures	undisclosed
09/05/24	$13,500,000	Seed Extension	Anzu Partners BoxOne Ventures Draper Associates Legend Star LYFE Capital RIT Venture Fund	undisclosed